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Coronary heart disease (CHD) is still the leading cause of death for adults worldwide. Traditional Chinese medicine (TCM) has a
history of 1000 years ﬁghting against the disease and provides a complementary and alternative treatment to it. Syndrome is the
core of TCM diagnosis and it is traditionally diagnosed based on macroscopic symptoms as well as tongue and pulse recognitions
of patients. Establishment of the diagnosis method in the microcosmic level is an urgent and major problem in TCM. The aim of
this study was to establish characteristic diagnosis pattern for CHD with Qi deﬁciency syndrome (QDS). Thirty-four biological
parametersweredetectedin52patientshavingunstableangina(UA)withorwithoutQDS.Then,wepresentedanoveldatamining
method, t-test-based Adaboost algorithm, to establish highest prediction accuracy with the least number of biological parameters
for UA with QDS. We gained a pattern composed of ﬁve biological parameters that distinguishes UA with QDS patients from non-
QDSpatients.Thediagnosisaccuracyofthepatternscouldreach84.5%basedona3-foldcrossvalidationtechnique.Moreover,we
included 85 UA cases collected from hospitals located in the north and south of China to further verify the association between the
pattern and QDS. The classiﬁcation accuracy is 83.5%, which keeps consistent with the accuracy obtained by the cross-validation
technique. The association between a symptom and the ﬁve biological parameters was established by the data mining method and
it reached an accuracy of ∼80%. These results showed that the t-test-based Adaboost algorithm might be a powerful technique for
diagnosing syndrome in TCM in the context of CHD.
1.Introduction
Coronary heart disease (CHD) remains the single leading
cause of death for adults worldwide [1]. Eﬀective prevention
and therapy for CHD poses a major challenge to the entire
medical community. Traditional Chinese medicine (TCM)
hasfoughtagainstCHDanditsrelateddiseasesformorethan
1000 years and has accumulated thousands of prescriptions
as well as clinical literatures. Therefore, more and more
patientsallovertheworldtakeTCMasacomplementaryand
alternative avenue to treat CHD.
TCM is a medical system with at least 3000 years of unin-
terrupted clinical practice and it has the advantage of collect-
ing macroscopic information (including symptoms, tongue
and pulse recognition) of a patient for diagnosis, while syn-
drome is the core of diagnosis and target of herbal remedy in
TCM. Nowadays, syndrome in TCM has been always studied
in the context of a speciﬁc disease or biomedical condition
and several literatures have demonstrated that syndromes
are signiﬁcantly associated with diseases [2, 3]. However, the
biological basis of a syndrome in the context of a disease is
rarely studied. The issue is signiﬁcantly critical since it not
only establishes a diagnosis avenue in microcosmic level, but
also divides the disease into several subtypes and provides a
basis for individual therapy.
Unstable angina (UA) is a type of CHD. It describes a
biomedical condition that is intermediate between myocar-
dial infarction (MI) and the more chronic state of stable
angina. UA is now a heavy burden on the society and families
in both industrialized and developing countries. So UA
presents a better example and context for investigating the
diagnosismethodandbiologicalbasisofsyndromesinTCM.
Qi deﬁciency syndrome (QDS) is an important syn-
drome in the UA with the frequency ∼70%. The symptoms2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: The ﬂowchart of data mining scheme.
as well as related tongue and pulse information that serve
as diagnosing QDS could be easily distinguished from UA
patients, such as spiritlessness, hypodynamia, short breath,
thin and fatty tongue as well as deep and thread pulse.
Themacroscopicphenotypesdohavecorrespondingchanges
in the microcosmic levels. Therefore, establishing diagnosis
method of syndromes in the microcosmic level plays a key
role in understanding biological basis of them and their
associated macroscopic phenotypes.
Traditionally, statistical methods used to investigate bio-
logical basis of syndrome or biomedical conditions often
focus on univariate methods such as Student’s t-test and
linear multivariate methods such as linear regression. These
methods pay little attention to the complex associations
between biological parameters in microcosmic level and
syndrome. Advanced statistical methods, or called data
mining methods, provide a better solution to establish the
nonlinear association between syndrome and biological pa-
rameters in microcosmic levels.
In this research, we presented a data mining-based strat-
egy to establish diagnosis pattern of syndrome in TCM
(Figure 1). We carried out clinical epidemiology surveys to
collect macroscopic information and related microcosmic
information. Based on the data and characteristic of it, we
presented a novel data mining methods that combined the
t-test with the Adaboost algorithm not only to choose as
few as microcosmic biological parameters associated with
QDS but also to establish a complex mathematic model for
diagnosingQDSbyusingtheselectedparameters.Themodel
had the ability to predict whether a UA patient is QDS.
Moreover, we carried out a similar epidemiology survey with
relatively large samples to test the accuracy and speciﬁcity of
theestablishedmodel.Wealsoinvestigatedanddiscussedthe
roles of selected parameters in UA and QDS.
2. Methods
2.1. Materials. Fifty-two UA in-patients aged between 55
and 75 years came from Dongzhimen Hospital aﬃliated to
Beijing University of Chinese Medicine and Hospital aﬃli-
ated to Inner Mongolia Medical College (from 1 November
2006 to 31 March 2008). Thirty-nine UA patients with
QDS and thirteen UA patients without QDS were included.
The syndromes of a patient were judged by three TCM
senior doctors with consistent diagnostic opinions according
to diagnosis criteria established in 1990s in China (the
appearance of all the following symptoms: lassitude and
short breath, pale enlarged and tender-soft tongue possibly
with teeth mark, sunken and ﬁne pulse).
Eligible patients in this paper were deﬁned as with UA
based on diagnosis criteria of UA established in 2002 by
ACC and AHA, i.e. chest pain at rest and transient S-T
segment changes, without signiﬁcant increases in creatine
kinase and creatine kinase MB fraction [4]. The criterion
for enrollment was admission within 48h after the onset of
chest pain. Moreover, the exclusion criteria were composed
of four conditions: (i) besides UA, a patient also suﬀers from
other cordis diseases such as acute myocardial infarction,
myocarditis and cardiac nerve functional disease; (ii) a pa-
tient with angina caused by other diseases, for example rheu-
matic fever, syphilis, congenital coronary anomalies, hyper-
trophic cardiomyopathy, cardiac mitral stenosis; (iii) besides
UA, a patient also suﬀers from stroke, diabetes, nephritis,
renal failure, pulmonary infection, urinary tract infection,Evidence-Based Complementary and Alternative Medicine 3
rheumatism, osteoarthritis, serious diseases caused by liver,
renal, hematogenous system, incretion system; (iv) a woman
patient in gestation or lactation.
All subjects gave informed consent and were approved by
the Medical Ethics and Human Clinical Trial Committee at
Dongzhimen Hospital or Hospital aﬃliated to Inner Mongo-
lia Medical College.
Itisnotedthatthehealthcontrolgroupisnotincludedin
this study since we only investigate syndrome in the context
ofadisease.ThecontrolofUAwithQDSisUAwithoutQDS.
2.2. Biological Parameter Detection. Thirty-four biological
parameters were detected on the 52 patients. The param-
eters included blood urea nitrogen (Bun), creatinine (Cr),
uric acid (URA), total CO2, alanine aminotransferase
(ALT), aspartate aminotransferase (AST), glutamyltrans-
ferase(GGT), total bilirubin (TBIL), direct bilirubin (DBIL),
indirect bilirubin (IBIL), high density lipoprotein (HDL),
low density lipoprotein (LDL), cholesterol (CHO), triglyc-
eride (TG), white blood count (WBC), red blood count
(RBC), hemoglobin (HGB), hematocrit (HCT), mean cell
volume (MCV), mean corpuscular hemoglobin (MCH),
mean corpuscular hemoglobin concentration (MCHC),
platelet count (PLT), mean platelet volume (MPV), platelet
distribution width (PDW), neutrophilic granulocyte abso-
lute value (NE), leukomonocyte absolute value (LY), mon-
onuclear cell absolute value (MO), acidophilic cell absolute
value (EO) and basophilic cell absolute value (BA).
These parameters were divided into four parts: elec-
trolyte, kidney and liver functions; blood routine and blood
lipid. They were included as a full set based on the following
two reasons. The ﬁrst one is that they are very commonly
used in clinical practice, which provides convenience for
further validation and popularization. The second is that
they are usually omitted in diagnosing syndrome in clinics
nowadays. Less attention is paid on associations between
them and syndromes, although they have some connections
with the disease.
It is also noted that the association between biological
parameters chosen here and the syndrome do not aﬀect
association between another parameters (such as inﬂamma-
tory systems) and the syndrome. Since we only established a
diagnosis avenue by several biological parameters for QDS,
these several parameters are part, not all, of biological basis
of the syndrome.
2.3. Data Mining Method: T-Test-Based Adaboost Algorithm.
We used the Student’s t-test to choose several speciﬁcations
with possible signiﬁcant diﬀerence between two subtypes
and ranked the included speciﬁcation by t-value calculated
for them. The t-value is calculated as follows: t = (X1 −
X2)/SX1−X2, ν = n1 − 1+n2 − 1 = n1 + n2 − 2, where
SX1−X2 =

S2
c(1/n1 +1 /n2), in which
S2
c =
(n1−1)S2
1+(n2−1)S2
2
n1 +n2 −2
=

(X1−X1)
2+

(X2−X2)
2
n1 +n2 −2
.
(1)
Where Xi, i = 1,2 denotes the mean value of a biological
parameter Xi with QDS and non-QDS respectively. ν repre-
sents freedom of the distribution. Here, n1 = 39, n2 = 13.
Si, i = 1,2 is responsible for standard derivation of the
parameter Xi respectively.
The t-value of a biological parameter reﬂects the degree
of diﬀerence between the QDS and the non-QDS group.
The higher the value, the more signiﬁcant the diﬀerence is
between the two groups.
We used the t-test here to rank the biological parameters
and formed a candidate pattern. The association between
several parameters and QDS is established by classiﬁcation
models. Decision tree(DT)isa kind ofclassiﬁcationsmodels
and hasbeen successfullyapplied in medical ﬁeld[5].Several
research outcomes have demonstrated that DT combined
with the boosting technique may improve classiﬁcation
accuracy and steadiness of the model [6]. Therefore, we used
DT combined with the boosting technique as a classiﬁcation
andpredictionmodeltobuildassociationbetweenbiological
parameters and QDS here. AdaBoost, short for Adaptive
Boosting, is a machine learning algorithm, formulated by
Yoav Freund and Robert Schapire [7]. It is a kind of so-
called meta-algorithms and it is embedded into classiﬁcation
methods to improve their predictive performance. AdaBoost
is adaptive in the sense that subsequent classiﬁers built are
tweaked in favor of those cases misclassiﬁed by previous
classiﬁers.
AdaBoost is a classiﬁer (Decision tree C4.5) [8] that is
used to establish association between biological parameters
and QDS repeatedly in a series of times, denoted as t =
1,2,...,N. For each time a distribution of weights Wt is
updated that indicates the importance of examples in the
clinical epidemiology data for the classiﬁcation. At each
time, the weights of each incorrectly classiﬁed example are
increased, so that the new classiﬁer focuses more on those
examples. A brief introduction of the Adaboost technique is
given as follows.
Given: (x1, y1),...,(xM, yM), where xi ∈ X, yi ∈ Y =
{1,−1}, X denotes biological parameters and Y denotes
QDS, Y = 1a n dY =− 1 mean that the case i is with
QDS and non-QDS respectively. M represents the number
of cases; here M = 52.
Initialize W1(i) = 1/M,f o rt = 1,2,...,N. Find the
classiﬁer Ct : X →{ +1,−1} that maximize the classiﬁ-
cation accuracy with respect to the distribution Wt: Ct =
argmin βjCj∈C,w h e r eβj =
M
i=1Wt(i)[yi / =Cj].
Usually, the prerequisite of βt is set as βt < 0.5 otherwise
the algorithm stops.
Choose a coeﬃcient αt = (1/2)ln((1 − βt)/βt), where βt
is the weighted error rate of classiﬁer Wt.
ThedistributionisupdatedasWt+1(i) = Wt(i)e−αtyiCt(xi)/
Zt,whe r eZt isanormalizationfactorthatmakestheupdated
Wt+1(i) be a probability distribution.
The ﬁnal classiﬁer is the output as C(x) = sign(
N
t=1αt
Ct(x)). Therefore, after selecting an optimal classiﬁer Ct
of the distribution Wt, the examples xi that the classiﬁer
Ct identiﬁed correctly are weighted less and those that
identiﬁed incorrectly are weighted more. As a result, when4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: The illustration of a 3-fold cross validation technique.
the Adaboost algorithm is testing the performance of the
distribution Wt+1, it will select a classiﬁer with better
classiﬁcation accuracy than its counterpart in the previous
classiﬁer missed [9, 10].
2.4. K-Fold Cross-validation. We used three performance
measures of all classiﬁcation methods: accuracy, sensitivity
and speciﬁcity to evaluate the association built. A distin-
guished confusion matrix was obtained to calculate the three
measures. The confusion matrix is a matrix representation
of the classiﬁcation results. The upper left cell denotes the
numberofsamples classiﬁedastrue whiletheyweretrue(i.e.
true positives, TP), and lower right cell denotes the number
of samples classiﬁed as false while they were actually false
(i.e. true false, TF). The other two cells (lower left cell and
upper right cell) denote the number of samples misclassiﬁed.
Speciﬁcally, the lower left cell denotes the number of samples
classiﬁed as false while they were actually true (i.e. false
negatives, FN), and the upper right cell denotes the number
of samples classiﬁed as true while they were actually false
(i.e. false positives, FP). Once the confusion matrixes were
constructed,theaccuracy,sensitivityandspeciﬁcityareeasily
calculated as sensitivity = TP/(TP + FN); speciﬁcity =
TN/(TN + FP); accuracy = (TP + TN)/(TP + FP + TN +
FN), where TP, TN, FP and FN denote true positives, true
negatives, false positives and false negatives, respectively
(Table 1)[ 5].
A 3-fold cross validation was used here to minimize the
bias produced by random sampling of the training and test
data samples (Figure 2).
The samples were equally divided into three parts. Each
time, two parts were used to build the model and the other
part was used to test the model. After three times, the
confusion matrix was obtained and classiﬁcation accuracy
could be calculated.
3. Results
3.1. Data Mining. Signiﬁcant diﬀerence was found in only
two biological parameters (MCH and CHO) (P<0.05)
between unstable angina with QDS patients and the non-
QDS patients. But the two biological parameters were not
enoughto distinguish theunstableangina withQDSpatients
from the non-QDS patients (Figure 4). So we chose 10
parameters to form a candidate subset from where the
biological parameters pattern would be discovered by data
mining methods (Figure 3).
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Figure 4: The t-test-based algorithm calculated diﬀerent biological
parameters combinations by nine times. The optimal number of
biological parameters is ﬁve.
After the t-test based Adaboost algorithm was used, we
gotthethreebestpatternswhosediagnosisaccuracyofunsta-
ble angina with QDS could reach 84.5% (Figure 4). Con-
sidering the value of clinical application, the fewer indexes,
the better; therefore, we prefer the pattern made by the ﬁve
following parameters (Tables 2 and 3).
3.2. Clinical Validation. In order to test the accuracy of asso-
ciationestablishedforQDSbyﬁveparameters.Were-carried
out a clinical epidemiology survey to collect full information
of both syndromes and ﬁve biological parameters. The
inclusion and exclusion criteria were consistent with the
former survey. Forty-two UA patients from hospital aﬃliated
toInnerMongoliaMedicalCollegeinnorthernpartofChina
and forty-three UA patients from hospital aﬃliated to Hubei
college of Chinese medicine from in southern part of China
were collected between June 2008 and March 2009 and wereEvidence-Based Complementary and Alternative Medicine 5
Table 1: TP, TN, FP and FN of the pattern.
Feature selection method TP FN FP TN Sensitivity (%) Speciﬁcity (%) Accuracy (%)
T-test based on Adaboost algorithm 35 4 5 8 89.7 61.5 84.5
Table 2: Using 52 samples, classiﬁcation models reach an accuracy of 100%.
Samples TP FN FP TN Sensitivity (%) Speciﬁcity (%) Accuracy (%)
Full samples 39 0 0 13 100 100 100
Table 3: The ﬁve indexes and their P value in the pattern included.
Biological parameter P-value
MCH 0.023899
CHO 0.027355
PDW 0.072665
LDL 0.083111
TCO2 0.11374
included to validate the model built by the t-test-based
Adaboost algorithm. We input the ﬁve biological parameters
into the prediction model. It would predict that if the case
was QDS, then the prediction results were compared with
diagnosis results by TCM experts, and the sensitivity, speci-
ﬁcity and accuracy were calculated. As depicted in Table 4,
it is found that the validation reached the accuracy of ∼
83%, which was in accordance with results obtained by a 3-
fold cross-validation. These evidences showed that the ﬁve
biological parameters did signiﬁcantly associate with QDS
and the prediction model had its conservation in diﬀerent
population and demographic area.
3.3. Association between Symptom That Related to QDS and
Five Biological Parameters. Since QDS is diagnosed by the
combinationofsymptomsaswellasrelatedtongueandpulse
information,theassociationbetweenQDSrelatedsymptoms
and the ﬁve parameters needs to be investigated. We used full
samples here with 137 UA patients to establish the associa-
tion. According to the basic theories of TCM, hypodynamia
is signiﬁcantly associated with QDS. Using the same data
mining method and a 3-fold cross-validation, it was found
that the classiﬁcation accuracy was ∼80% (Table 5).
4. Discussion
Nowadays, the diagnosis of syndromes in TCM mainly de-
pends on four examinations (inspection, listening and smel-
ling examination, inquiry and palpation). Thus, the accuracy
is relatively low. If objective indexes can be used in the
diagnosis of syndrome in TCM, the accuracy could be sig-
niﬁcantly improved.
During the past decades, the researches on the biological
basis of diseases and TCM syndromes have encountered a
bottleneck due to the direction of ﬁnding the “golden indi-
cator” for the diagnosis of disease or syndrome. However,
the syndrome is a holistic concept and its scientiﬁc content
may need an overall review on organisms. Maybe there is no
“golden indicator” for the diagnosis of a syndrome at all. The
researches on syndromes should not be restricted in ﬁnding
the “golden indicator.”
Withthedevelopment ofsystembiology,thedatamining
technique becomes more and more mature. Its advantages
are very applicable to the complex correlativity study of
macroscopic TCM symptom and microcosmic parameters.
We had used decision tree as the data mining method to
the study of the relation between symptom in TCM and
biological parameter [11]a n dm a d eal o to fp r o g r e s s .
In this paper, we took the t-test based Adaboost algo-
rithm as a feature selection method to establish the diagnosis
pattern of QDS in the context of UA for three reasons. The
ﬁrst one is that the algorithm is very simple to implement.
The second one is that it performs feature selection on large
sets of features. The ﬁnal reason is that it is with fairly good
generalization.
Among the ﬁve parameters, CHO and LDL have been
proposed to be independent predictors of atherosclerotic
vascular disease [12, 13]. CHO is an essential component of
cell membranes where it is required to establish the proper
permeability and ﬂuidity of membrane. In addition, CHO is
an important precursor molecule for the biosynthesis of bile
acids,steroidhormonesandseveralfatsolublevitamins[14].
But high CHO is one of the major risk factors for developing
heart disease. LDL molecules are the major carriers of CHO
in the blood. It is a type of lipoprotein that transports
CHO and triglycerides from the liver to peripheral tissues.
It has been accepted as an emerging cardiovascular risk
factor by the National Cholesterol Education Program Adult
Treatment Panel III [15]. LDL concentration is an important
predictor of cardiovascular events and progression of coro-
nary artery disease [16].
PDW may relate to QDS. PDW expresses the distribution
of the size of platelets produced by the megakaryocyte.
Although PDW have been available now for quite a long
time, their clinical usefulness hitherto is not obvious. PDW
has been found highly useful in the diﬀerential diagnosis
of thrombocytosis [17]. Thrombocytosis relates with the
blood stasis syndrome which always leads to QDS because,
according to TCM, blood is the vehicle of Qi.
MCH and TCO2 may both associate with cardiovascular
disease and QDS. MCH is the average mass of hemoglobin
per red blood cell in a sample of blood. Hemoglobin is
the iron-containing oxygen-transport metalloprotein in the
red cells of the blood in human. Hemoglobin transports
oxygen from the lungs to the rest of the body where it
releases the oxygen. We need more oxygen and usually feel6 Evidence-Based Complementary and Alternative Medicine
Table 4: The clinically further validation of the association established: it is found that the results are in accordance with the cross-validation
counterpart.
Region Total QDS Non-QDS TP FN FP TN Sensitivity (%) Speciﬁcity (%) Accuracy (%)
NeiMeng region 42 29 13 25 4 3 10 86.2 76.9 83.3
Hubei region 43 31 12 26 5 2 10 83.9 83.3 83.7
Total 85 60 25 51 9 5 20 85 80 83.5
Table 5: The association between symptom and the ﬁve biological parameters was established by the algorithm.
Samples TP FN FP TN Sensitivity (%) Speciﬁcity (%) Accuracy (%)
Full samples 79 11 17 30 87.7 63.8 79.6
The classiﬁcation accuracy is ∼80%.
t i r e di ns p o r t s .I n s u ﬃcient oxygen transportation usually
leads to short breath and lassitude, which are the typical
symptoms of QDS. MCH might be a reﬂection of QDS.
Hemoglobin also has a variety of other gas-transport and
eﬀect-modulation function. It has been reported to have
association with heart failure [18]. TCO2 is a reﬂection of
acid-basebalance.MeasurementofthetotalCO2 content can
help us explain acid-base balance disorders. It is relative with
thebreathoflungs.Sportscanincreaserespiratoryfrequency
and cause tiredness, lassitude and short breath which are
important characteristics of QDS. Thus, TCO2 appeared in
our diagnosis pattern of QDS is reasonable. It has been
reported that there is a relationship between breath obstacle
and cardiovascular disease [19].
To sum up, the associated biomedical literatures support
the ﬁnding. The ﬁve parameters are certainly ignored in clin-
ics. However, we found that they are useful in the diagnosis
pattern for UA with QDS.
In the pattern made by ﬁve biological parameters, P
values of only two indexes (MCH and CHO) were <0.05. P
values of PDW, LDL and TCO2 exceeded 0.05, which sug-
gests that the three parameters has no signiﬁcant diﬀerence
between QDS and non-QDS respectively. However, com-
bined and associated with the other two biological param-
eters, the classiﬁcation model reaches a highest accuracy,
which suggests that the ﬁve parameters have signiﬁcant
diﬀerence between the two groups.
So many documents have shown that inﬂammation sys-
tem has signiﬁcantly associated with UA and the syndromes
in the context of it [11]. A syndrome called blood stasis
syndrome was found to be diagnosed by several inﬂam-
mation parameters. However, the association between QDS
and inﬂammation system is not studied in the paper; the
diagnosis accuracy of QDS by using biological parameters
from inﬂammation system is need to be further investigated
in our continuous research eﬀorts and be compared with the
results obtained in the paper.
The further research directions would focus on three
parts. The ﬁrst is to enlarge the amount of clinical epidemi-
ology samples and use the data mining methods to establish
diagnosis methods for all syndromes in the context of UA,
i.e. diﬀerentiate diagnosis. Alternatively, the association of
ﬁve biological parameters and QDS needs to be investigated
by using animal models to study the inner mechanism of
it. Finally, the diagnosis pattern should be studied in the
context of other diseases than UA, which provides a basis for
uncovering the biological basis of syndrome in TCM.
5. Conclusion
This study was devoted to establish the diagnosis method
of QDS by using microcosmic biological parameters in the
context of UA. We presented a novel data mining method to
select ﬁve parameters: MCH, CHO, PDW, LDL and TCO2
to form a diagnosis pattern that distinguishes QDS from UA
patients.Thehighestdiagnosisaccuracyofthepatternscould
reach 84.5%. The further clinical validation showed that
the ﬁve parameters have signiﬁcant association with QDS
in the context of UA. The association between symptoms
that are signiﬁcantly associated with QDS also conﬁrms
the ﬁnding. We conclude that the syndrome in TCM can
be diagnosed in the microcosmic level and the t-test-based
Adaboost algorithm may have high value in diagnosis in the
clinics.
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